HCA Healthcare, Inc.
HCA Healthcare, Inc. (HCA) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.
• HCA is the largest for-profit hospital operator in the country, and its scale lets it raise revenue per admission even when volumes are soft: Q1 2026 revenue rose 4.3% to $19.1 billion while same-facility admissions grew under 1%. [Source: HCA Q1 2026 earnings release] • The biggest risk is the balance sheet, not the operations: net debt of roughly $53 billion sits at about 5.6 times operating income, and the company runs with negative book equity by design. • Watch volume normalization and th
Is HCA overvalued? See what's priced in →
1,372 institutional managers reported holding HCA in 13F filings for the quarter ended 2026-03-31. Together they hold about 57% of the company; the top 10 hold 29%. 122 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 5.2M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
HCA has cut its share count 31.9% over the past five years, spending $32.89B on repurchases. It pays a dividend, and has for 8 years running, raised 5 years straight; the current rate is $2.88 a share annually. Cash returned over the past three years: $1.87B in dividends and $19.73B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at HCA over the trailing three years. Absence is a fact about the company, not a signal. 25 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
HCA's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-03 | -3.2% | -9.3% |
| 2023-10-27 | -6.4% | +20.2% |
| 2024-02-17 | +6.4% | -1.1% |
| 2024-05-03 | -0.6% | +4.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
HCA's latest 8-K filings: 2026-07-14 (items 2.02, 7.01, 9.01); 2026-06-18 (items 5.02); 2026-04-30 (items 1.01, 2.03, 8.01, 9.01); 2026-04-28 (items 5.07); 2026-04-27 (items 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.